Recall: D-0389-2024

Class III - Minor Violations

Class IIIClassification

2024-03-04Initiated

TerminatedStatus

Novitium Pharma LLCFirm

Product

Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20

Reason

Cross Contamination with Other Products:(mycophenolate mofetil).

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.